Reading Materials

  

General
_________________________________________________________________________________________


Anderson JR, Barret RL (eds). Ethics and HIVAIDS: Clinical decision-making with complex cases. Washington, DC. American Psychological Association, 2001.

Basso, M. R., & Bornstein, R. A. (2000a).  Effects of immunosuppression and disease severity upon neuropsychological function in HIV infection.  Journal of Clinical and Experimental Neuropsychology 22, 104-114.

Belar CD, Deardorff W. Clinical health psychology in medical settings: a practitioner’s guidebook. Washington, DC. American Psychological Association, 1996.

Cohen, R. A., Boland, R., Paul, R., Tashima, K. T., Schoenbaum, E. E., Celentano, D. D., Schuman, P., Smith, D. K., & Carpenter, C. C. J. (2001).  Neurocognitive performance enhanced by highly active antiretroviral therapy in HIV-infected women.  AIDS 15, 341-345.

Cohen MA, , Goforth HW, Lux JZ, Batista SM, Khalife S, Cozza KL, and Soffer J.  Handbook of AIDS Psychiatry. New York, NY. Oxford University Press, 2010.

Cohen MA, Gorman J (eds).  Comprehensive Textbook of AIDS Psychiatry.  New York, NY.  Oxford University Press, 2008.

Cournos F, Bakalar N. AIDS and people with severe mental health: a handbook for mental health professionals. New Haven, CT. Yale Press, 1996.

Cournos F, Forstein M (eds). What Mental Health Practitioners Need to Know About HIV and AIDS. New Directions in Mental Health Services, Jossey-Bass, (87), Fall 2000.

Fernandez F, Ruiz P (eds)..  Psychiatric Aspects of HIV/AIDS.  Philadelphia, PA. Lippincott, Williams & Wilkins,  2006.

Ferrando S, van Gorp W, McElhiney M, Goggin K, Sewell M, Rabkin J. Highly active antiretroviral treatment in HIV infection: benefits for neuropsychological function. AIDS 12: F65-F70, 1998.

Odets W, Shernoff M. The second decade of AIDS: a mental health practice handbook. New York, NY. Hatherleigh Press, 1995.

Rabkin J, Remien R, Wilson C. Good doctors, good patients: partners in HIV treatment. New York, NY. NCM Publishers, Inc., 1994.

Tozzi, V, Balestra, P, Galgani, S, Narciso, P, Sampaolesi, A, Antinori, A, Giulianelli, M, Serraino, D, & Ippolito, G (2001).  Changes in neurocognitive performance in a cohort of patients treated with HAART for 3 years.  Journal of Acquired Immune Deficiency Syndromes  28, 19-27.

Treisman J, Angelino, A, The Psychiatry of AIDS: A Guide to Diagnosis and Treatment.  Baltimore and London, Johns Hopkins University Press, 2004.

Wallace, M. R., Nelson, J. A., McCutchan, J. A., Wolfson, T., & Grant, I. (2001).  Symptomatic HIV seroconverting illness is associated with more rapid neurological impairment.  Sexually Transmitted Infections 77, 199-201.

Winiarski MG. HIV mental health for the 21st century. New York, NY. New York University Press, 1997.

 

Neuropsychiatric  Manifestations 

______________________________________________________________________________________________

Atkinson JH, Grant I. Natural history of neuropsychiatric manifestation of HIV disease. In Zegans L, Coates TJ (eds). Psychiatric Manifestations of HIV Disease. Psychiatric Clinics of North America, Vol. 17(1). Philadelphia? WB Saunders. 17-34, 1994.

Chang, L., Ernst, T., Leonido-Yee, M., Witt, M., Speck, O., Walot, I., & Miller, E. N. (1999).  Highly active antiretroviral therapy reverses brain metabolite abnormalities in mild HIV dementia.  Neurology 53, 782-789.

De Luca, A., Giancola, M. L., Ammassari, A., Grisetti, S., Paglia, M. G., Gentile, M., Cingolani, A., Murri, R., Liuzzi, G., Monforte, A. D., & Antinori, A. (2000).  The effect of potent antiretroviral therapy and JC virus load in cerebrospinal fluid on clinical outcome of patients with AIDS-associated progressive multifocal leukoencephalopathy.  Journal of Infectious Diseases 182, 1077-1083. 

Dore, G. J., Correll, P. K., Li, Y., Kaldor, J. M., Cooper, D. A., & Brew, B. J. (1999).  Changes to AIDS dementia complex in the era of highly active antiretroviral therapy.  AIDS 13, 1249-1253.
Fernandez F, Adams F, Levy JK, Holmes VF, Neidhart M, Mansell PW. Cognitive impairment due to AIDS-related complex and its response to psychostimulants. Psychosomatics 29: 38-46, 1988.

Fernandez F, Levy JK, Mansell PW. Management of delirium in terninally ill AIDS patients. International Journal of Psychiatry in Medicine. 19(2): 165-172, 1989.

Goodkin K, Wilkie FL, Concha J, et al. Subtle neuropsychological impairment and minor cognitive-motor disorder in HIV-1 infection: neuroradiological, neurophysiological, neuroimmunological, and virological correlates. Neuroimaging Clin N Am 7: 561-579, 1997.

Levy RM, Bredesen DE. Controversies in HIV-related central nervous system disease: Neuropsychological aspects of HIV-1 infection. In Volberding P, Jacobsen M (eds). AIDS Clinical Review. New York: Michael Dekker, Inc., 1989.

McArthur JC, Hoover DF, Bacellar H, et al. Dementia in AIDS patients: incidence and risk factors. Neurology 43: 2245-2252, 1993.

Navia BA, Jordan BC, Price RW. The AIDS dementia complex: I. Clinical features. Ann Neurol 19: 517-524, 1986.

Perry S, Jacobsen P. Neuropsychiatric manifestations and AIDS spectrum disorders. Hospital and Community Psychiatry. 37(2): 135-142, 1986.

Stankoff, B., Tourbah, A., Suarez, S., Turell, E., Stievenart, J. L., Payan, C., Coutellier, A., Herson, S., Baril, L., Bricaire, F., Calvez, V., Cabanis, E. A., Lacomblez, L., & Lubetzki, C. (2001).  Clinical and spectroscopic improvement in HIV-associated cognitive impairment.  Neurology 56, 112-115.

Stern, Y., McDermott, M. P., Albert, S., Palumbo, D., Selnes, O. A., McArthur, J., Sacktor, N., Schifitto, G., Kieburtz, K., Epstein, L., & Marder, K. S. (2001).  Factors associated with incident human immunodeficiency virus-dementia.  Archives of Neurology 58, 473-479.

Suarez, S., Baril, L., Stankoff, B., Khellaf, M., Dubois, B., Lubetzki, C., Bricaire, F., & Hauw, J. (2001).  Outcome of patients with HIV-1-related cognitive impairment on highly active antiretroviral therapy.  AIDS 15, 195-200.

Tantisiriwat, W., Tebas, P., Clifford, D. B., Powderly, W. G., & Fichtenbaum, C. J. (1999).  Progressive multifocal leukoencephalopathy in patients with AIDS receiving highly active antiretroviral therapy.  Clinical Infectious Diseases 28, 1152-1154.

Tassie, J. M., Gasnault, J., Bentata, M., Deloumeaux, J., Boue, F., Billaud, E., & Costagliola, D. (1999).  Survival improvement of AIDS-related progressive multifocal leukoencephalopathy in the era of protease inhibitors. Clinical Epidemiology Group. French Hospital Database on HIV.  AIDS 13, 1881-1887.

Van Gorp WG, Buckingham SL. Practitioners guide to the neuropsychiatry of HIV/AIDS. New York, NY. The Guilford Press, 1998. 

Psychiatric Syndromes

___________________________________________________________________________________________________________

American Psychiatric Association. Practice Guideline for the Treatment of Patients with HIV/AIDS. Am J Psychiatry (suppl). 157:11, November 2000.

 Atkinson JH, Grant I, Kennedy CH, Richam DD, Spector SA, McCutchan A: Prevalence of psychiatry disorders among men infected with human immunodeficiency virus. Arch Gen Psychiatry . 45(9): 859-864, 1988.

Beckett A, Shenson D: Suicide risk in HIV infection and AIDS. Harvard Rev Psychiatry. 1:27-35, 1993.

Cadwell S, Burnham R, Forstein M (eds). Therapists on the Front Line: Psychotherapy with gay men in the age of AIDS. American Psychiatric Press, Inc., 1994.

Canadian Psychiatric Association. HIV & Psychiatry: A training and resource manual AIDS Care, Treatment and Support Program, National AIDS Contribution Program of the National AIDS Strategy, Health Canada, Canadian Psychiatric Association.

Catalan J, Riccio M: Psychiatric disorders associated with HIV disease. AIDS Care 2(4):547-562, 1990.

Chuang HT, Jason GW, Pajurkova EM, Gill MJ. Psychiatric morbidity in patients with HIV infection. Am J Psychiatry 37: 109-115, 1992.

Darko, F, McCutchan JA, Kripke DV, et al. Fatigue, sleep disturbance, disability, and indices of progression of HIV infection. Am J Psychiatry 149: 514-520, 1992.

Ferrando S, Wall T, Batki S, Sorensen J. Psychiatric disorders, illicit drug use and adherence to zidovudine (AZT) among injection drug users with HIV disease, American J Drug and Alcohol Abuse 22:475-487, 1996.

Lyketsos CG, Fishman M, Hutton H, et al. The effectiveness of psychiatric treatment for HIV-infected patients. Psychosomatics 38: 423-432, 1997.

Mijch, A. M., Judd, F. K., Lyketsos, C. G., Ellen, S., & Cockram A. (1999).  Secondary mania in patients with HIV infection: Are antiretrovirals protective?  Journal of Neuropsychiatry and Clinical Neurosciences 11, 475-480.

Naber D, Riedel RR, Niederecker M. HIV infection and psychosis. Int Conf AIDS, 6(2):391, 20-23, 1990.

Psychiatric Annals: a journal of continuing psychiatric education. Aspects of HIV Infection and AIDS.  Psychiatric Annals 31:1, January 2001.

Rabkin JG. Prevalence of psychiatric disorders in HIV illness. International Review of Psychiatry 8: 157-166, 1996.

 

Counseling and Assessment

______________________________________________________________________________________________________________


Ayuso-Mateos, J. L., Pereda, M., Gómez del Barrio, A., Echevarria, S., Fariñas, M. C., & García-Palomo, D. (2000). 

Slowed reaction time in HIV-1-seropositive intravenous drug users without AIDS.  European Neurology 44, 72-78.

Basso, M. R., & Bornstein, R. A. (2000b).  Estimated premorbid intelligence mediates neurobehavioral change in individuals infected with HIV across 12 months.  Journal of Clinical and Experimental Neuropsychology 22, 208-218.

Bisiacchi, P. S., Suppiej, A., & Laverda, A. (2000).  Neuropsychological evaluation of neurologically asymptomatic HIV-infected children.  Brain and Cognition 43, 49-52.

Boccellari A. Assessing and diagnosing AIDS dementia complex. In AIDS Dementia Complex Training Manual. San Francisco: Family Survival Project, 1990.

Boccellari A, Davis A, Dilley JW. Preliminary findings on a screening checklist for HIV dementia. Presentation from the V International Conference on AIDS, Montreal, Canada, 1989.

Boccellari AA, Dilley JW. Management and residential placement problems of patients with HIV-related cognitive impairment. Hospital and Community Psychiatry. 43 (1): 32-37, 1993.

Boccellari AA, Dilley JW, Davis A, et al.  The Neuropsychiatric AIDS Checklist: Its relationship to HIV status, immune functioning and performance. Presentation from the VI International Conference on AIDS, San Francisco, June 1990.

Boccellari A, Shore M, Stroad M. Neuropsychologic assessment in HIV-related disorders. In Cohen PT, Sande MA, Volberding PA (eds). The AIDS Knowledge Base. Boston: Little, Brown & Company. 5-32, 1994.

Castellon, S. A., Hinkin, C. H., & Myers, H. F. (2000).  Neuropsychiatric disturbance is associated with executive dysfunction in HIV-1 infection.  Journal of the International Neuropsychological Society 6, 336-347.

Coscia, J. M., Christensen, B. K., Henry, R. R., Wallston, K., Radcliffe, J., & Rutstein, R. (2001).  Effects of home environment, socioeconomic status, and health status on cognitive functioning in children with HIV-1 infection.  Journal of Pediatric Psychology 26, 321-329.

Davis, H. F., Skolasky, R. L. Jr., Selnes, O. A., Burgess, D. M., & McArthur, J. C. (2002).  Assessing HIV-associated dementia: Modified HIV dementia scale versus the Grooved Pegboard.  The AIDS Reader 12, 29-31, 38.

Dilley JW, Pies C, Helquist M. Face to Face: A guide to AIDS Counseling. AIDS Health Project Univ. California, San Francisco, 1993.

 Durvasula, R. S., Miller, E. N., Myers, H. F., & Wyatt, G. E. (2001).  Predictors of neuropsychological performance in HIV positive women.  Journal of Clinical and Experimental Neuropsychology 23, 149-163.

 Durvasula, R. S., Myers, H. F., Satz, P., Miller, E. N., Morgenstern, H., Richardson, M. A., Evans, G., & Forney, D. (2000).  HIV-1, cocaine, and neuropsychological performance in African American men.  Journal of the International Neuropsychological Society 6, 322-335.

Fishkin, P. E., Armstrong, F. D., Routh, D. K., Harris, L., Thompson, W., Miloslavich, K., Levy, J. D., Johnson, A., Morrow, C., Bandstra, E. S., Mason, C. A., & Scott, G. (2000).  Relationship between HIV infection and WPPSI-R performance in preschool-age children.  Journal of Pediatric Psychology 25, 347-351.

Giesen, H. -J. v., Bäecker, R., Hefter, H., & Arendt, G. (2001).  Depression does not influence basal ganglia-mediated psychomotor speed in HIV-1 infection.  Journal of Neuropsychiatry and Clinical Neurosciences 13, 88-94.

Hinkin, C. H., Castellon, S. A., & Hardy, D. J. (2000).  Dual task performance in HIV-1 infection.  Journal of Clinical and Experimental Neuropsychology 22, 16-24.

Knippels, H. M., Goodkin, K., Weiss, J. J., Wilkie, F. L., & Antoni, M .H. (2002).  The importance of cognitive self-report in early HIV-1 infection: Validation of a cognitive functional status subscale.  AIDS 16, 259-267.

Leary M, Zeifert P. Clinical evalluation and management of HIV dementia. In Cohen PT, Sande MA, Volberding PA (eds). The AIDS Knowledge Base. Boston: Little, Brown & Company. 5-33, 1994.

Lewis Sy, Jue S. (in review). Ethical and cultural issues in HIV psychotherapy. In J Anderson/R Barret (eds), Ethical issues in HIV-related psychotherapy, Washington, DC. The American Psychological Association.

Lezak M. Neuropsychological Assessment, 2nd ed. New York: Oxford University Press, 1983.

Loveland, K. A., Stehbens, J. A., Mahoney, E. M., Sirois, P. A., Nichols, S., Bordeaux, J. D., Watkins, J. M., Amodei, N., Hill, S. D., Donfield, S., & the Hemophilia Growth and Development Study. (2000).  Declining immune function in children and adolescents with hemophilia and HIV infection: Effects on neuropsychological performance.  Journal of Pediatric Psychology 25, 309-322.

Marcotte, T. D., Heaton, R. K., Wolfson, T., Taylor, M. J., Alhassoon, O., Arfaa, K., Grant, I., & HNRC Group. (1999).  The impact of HIV-related neuropsychological dysfunction on driving behavior.  Journal of the International Neuropsychological Society 5, 579-592.

Martin, E. M., Pitrak, D. L., Novak, R. M., Pursell, K. J., & Mullane, K. M. (1999).  Reaction times are faster in HIV-seropositive patients on antiretroviral therapy: A preliminary report.  Journal of Clinical and Experimental Neuropsychology 21, 730-735.

Maschke, M., Kastrup, O., Esser, S., Ross, B., Hengge, U., & Hufnagel, A. (2000).  Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy.  Journal of Neurology, Neurosurgery and Psychiatry 69, 376-380.

Pereda, M., Ayuso-Mateos, J. L., del Barrio, A. G., Echevarria, S., Farinas, M. C., Palomo, D. G., Macias, J. G., & Vazquez-Barquero, J. L. (2000).  Factors associated with neuropsychological performance in HIV-seropositive subjects without AIDS.  Psychological Medicine 30, 205-217.

Strub RL, Black FW. Mental Status Examinations in Neurology. 3rd ed. Philadelphia: FA Davis, 1993.

Winiarski, MG. AIDS-related psychotherapy. New York, NY. Pergamon Press, 1991.

York, M. K., Franks, J. J., Henry, R. R., & Hamilton, W. J. (2001).  Verbal working memory storage and processing deficits in HIV-1 asymptomatic and symptomatic individuals.  Psychological Medicine 31, 1279-1291.

 

Treatment Interventions

___________________________________________________________________________________________________________

American Psychiatric Association: Delirium: A Patient and Family Guide. Washington, DC.  American Psychiatric Association, 1999.

Boccellari AA, Dilley JW. Management and residential placement problems of patients with HIV-related cognitive impairment. Hosp Community Psychiatry 43:32-37, 1992.

Boccellari A, Zeifert P. Management of neurobehavioral impairment in HIV-1 infection. In Zegans L, Coates TJ (eds). Psychiatric Manifestations of HIV Disease. Psychiatric Clinics of North America, Vol. 17 (1). Philadelphia: WB Saunders. 183-204, 1994.

Zeifert P, Leary M, Boccellari A. Treating and managing cognitive impairment. AIDS and the Impact of Cognitive Impairment: A treatment guide for mental health providers. UCSF AIDS Health Project: Monograph series number one. 41-72, 1995.